“Harnessing Nanoemulsion Technology for Enhanced Delivery of Canagliflozin in Type 2 Diabetes Therapy” (2025) Asian Journal of Pharmaceutics (AJP), 19(2). doi:10.22377/ajp.v19i2.6497.